Send feedback

ALG9 p.Arg554Trp

c.1660C>T · rs782084496 · VCV302425

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 3 submitters
AlphaMissense
likely benign
0.1199 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00644%, nfe)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
1
ALG9-congenital disorder of glycosylation

Computational evidence

Protein change
AlphaMissense0.1199likely benign
REVEL0.471indeterminate
SaProtLLR -10.50damaging
⇒ SaProt calls this damaging; AlphaMissense does not; REVEL is indeterminate.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 5.8GERP 1.1, phastCons 1
Regional constrainto/e 0.87unconstrained · MANE · 54 kb · p 0.028 · regional, not allelic
Overall
CADD25.3PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R547W vs ClinVar R554W) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00644% European (non-Finnish) · 76/1,179,966 alleles
Filtering AF 0.00528% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00482%
Overall 0.00551% 89/1,613,894 alleles · very rare exomes 84/1,461,812 · genomes 5/152,082 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.00937% 10,670
European (non-Finnish)grpmax 0.00644% 15,526
African / African-American 0.00401% 24,961
East Asian 0.00223% 44,896
Admixed American 0.00167% 59,980
Remaining individualsnot grpmax-eligible 0.0016% 62,480
South Asian 0.0011% 91,070

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ALG9
Protein
p.Arg554Trp
Coding
c.1660C>T
MANE Select
NM_024740
dbSNP
rs782084496
Type
single nucleotide variant
Location
chr11:111809716 (GRCh38)
Gene constraint
LOEUF 0.853 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 88.35 · 2 PDB
Full ALG9 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

ALG9-congenital disorder of glycosylation — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For ALG9-CDG (Orphanet):

Inheritance
Autosomal recessive
Onset
Antenatal, Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/alg9-p-arg554trp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown